Targeting lipid metabolism in metastatic prostate cancer

Despite key advances in the treatment of prostate cancer (PCa), a proportion of men have de novo resistance, and all will develop resistance to current therapeutics over time. Aberrant lipid metabolism has long been associated with prostate carcinogenesis and progression, but more recently there has...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheinberg, Tahlia, Mak, Blossom, Butler, Lisa, Selth, Luke, Horvath, Lisa G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893394/
https://www.ncbi.nlm.nih.gov/pubmed/36743527
http://dx.doi.org/10.1177/17588359231152839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893394/
https://www.ncbi.nlm.nih.gov/pubmed/36743527
http://dx.doi.org/10.1177/17588359231152839

Ejemplares similares